Lori Lyons-Williams

CIK 1693564 · Chief Commercial Officer · last filed 2026-03-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$171.1K

Companies

5

Total Filings

19

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RAPT Therapeutics, Inc. (RAPT) Delisted Director 4,956 $58.01 $287.5K $0 6 2026-02-02
CTNM Director $11.88 $0 2 2025-06-26
FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted Director $38.00 $0 2 2021-04-19
DERM Chief Commercial Officer 26,983 $6.34 $171.1K $0 6 2019-08-19
FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Director $178.75 $0 1 2019-06-25

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-05-15 FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted Grant (A) $0 EDGAR
2020-02-24 Disp (D) −25,401 -$476.3K
2019-08-19 DERM Mixed +1,607 -$12.5K EDGAR
2019-06-25 FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Grant (A) $0 EDGAR
2019-05-21 DERM Mixed +19,626 -$108.9K EDGAR
2019-02-14 DERM Grant (A) $0 EDGAR
2018-08-17 DERM Mixed +695 -$3.5K EDGAR
2018-02-16 DERM Grant (A) $0 EDGAR
2017-01-10 DERM Grant (A) $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.